Cited by 1,763Cardiac pacing and defibrillation studiesCardiac Arrest and ResuscitationHeart Failure Treatment and Management

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

Open access

Køber, Lars, Thune, Jens J., Nielsen, Jens C., Haarbo, Jens, Videbæk, Lars, Korup, Eva, Jensen, Gunnar, Hildebrandt, Per, Steffensen, Flemming H., Bruun, Niels E., Eiskjær, Hans, Brandes, Axel, Thøgersen, Anna M., Gustafsson, Finn, Egstrup, Kenneth, Videbæk, Regitze, Hassager, Christian, Svendsen, Jesper H., Høfsten, Dan E., Torp-Pedersen, Christian, Pehrson, Steen·2016·New England Journal of Medicine

DOI 10.1056/nejmoa1608029

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The benefit of an implantable cardioverter-defibrillator (ICD) in patients with symptomatic systolic heart failure caused by coronary artery disease has been well documented. However, the evidence for a benefit of prophylactic ICDs in patients with systolic heart failure that is not due to coronary artery disease has been based primarily on subgroup analyses. The management of heart failure has improved since the landmark ICD trials, and many patients now receive cardiac resynchronization therapy (CRT). METHODS: In a randomized, controlled trial, 556 patients with symptomatic systolic heart failure (left ventricular ejection fraction, ≤35%) not caused by coronary artery disease were assigned to receive an ICD, and 560 patients were assigned to receive usual clinical care (control group). In both groups, 58% of the patients received CRT. The primary outcome of the trial was death from any cause. The secondary outcomes were sudden cardiac death and cardiovascular death. RESULTS: After a median follow-up period of 67.6 months, the primary outcome had occurred in 120 patients (21.6%) in the ICD group and in 131 patients (23.4%) in the control group (hazard ratio, 0.87; 95% confidence interval [CI], 0.68 to 1.12; P=0.28). Sudden cardiac death occurred in 24 patients (4.3%) in the ICD group and in 46 patients (8.2%) in the control group (hazard ratio, 0.50; 95% CI, 0.31 to 0.82; P=0.005). Device infection occurred in 27 patients (4.9%) in the ICD group and in 20 patients (3.6%) in the control group (P=0.29). CONCLUSIONS: In this trial, prophylactic ICD implantation in patients with symptomatic systolic heart failure not caused by coronary artery disease was not associated with a significantly lower long-term rate of death from any cause than was usual clinical care. (Funded by Medtronic and others; DANISH ClinicalTrials.gov number, NCT00542945 .).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1608029

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 20,604
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction
Moss, A. J., Zaręba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,885
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., Carson, P., DiCarlo, L., DeMets, D., White, B. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032423 · Cited by 5,812
Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165
2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8807 · Cited by 3,304
A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease
Buxton, A. E., Lee, K. L., Fisher, J. D., Josephson, M. E., Prystowsky, E. N., & Hafley, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912163412503 · Cited by 2,489
Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy
Kadish, A. H., Dyer, A. R., Daubert, J. P., Quigg, R. J., Estes, N. A. M., Anderson, K. P., Calkins, H. G., Hoch, D., Goldberger, J. J., Shalaby, A. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033088 · Cited by 2,078
Reduction in Inappropriate Therapy and Mortality through ICD Programming
Moss, A. J., Schuger, C. D., Beck, C. A., Brown, M. W., Cannom, D. S., Daubert, J. P., Estes, N. A. M., Greenberg, H., Hall, W. J., Huang, D. T.-C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211107 · Cited by 1,369

Flagged first, then by citations

Show all 18 references

Sorted by citations

Items 301–400 of 999

Device complications with addition of defibrillation to cardiac resynchronisation therapy for primary prevention
Barra, S., Providencia, R. A., Bovéda, S., Duehmke, R. M., Narayanan, K., CHOW, A. W. C., Piot, O., Klug, D., Defaye, P., Gras, D., et al. (2018) · Heart · doi:10.1136/heartjnl-2017-312546 · Cited by 31
Sinergy between drugs and devices in the fight against sudden cardiac death and heart failure
Boriani, G., Ponti, R. D., Guerra, F., Palmisano, P., Zanotto, G., D’Onofrio, A., & Ricci, R. P. (2020) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaa015 · Cited by 32
Sudden cardiac death in newly diagnosed non-ischaemic or ischaemic cardiomyopathy assessed with a wearable cardioverter-defibrillator: the German nationwide SCD-PROTECT study
Duncker, D., Marijon, É., Metra, M., Piot, O., Fudim, M., Siebert, U., Frey, N., Maier, L. S., & Bauersachs, J. K. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf668 · Cited by 30
Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy
Moheb, M. N. E., Nicolas, J., Khamis, A. M., Iskandarani, G., Akl, E. A., & Refaat, M. M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012738.pub2 · Cited by 30
Implantable cardioverter-defibrillator in Chagas heart disease: A systematic review and meta-analysis of observational studies
do Carmo, A. A. L., de Sousa, M. R., Agudelo, J. F., Boersma, E. H., Rocha, M. O. D. C., Ribeiro, A. L. P., & Morillo, C. A. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.05.091 · Cited by 30
Update on the Diagnostic Pitfalls of Autopsy and Post-Mortem Genetic Testing in Cardiomyopathies
Grassi, S., Campuzano, Ó., Coll, M., Cazzato, F., Sarquella‐Brugada, G., Rossi, R., Arena, V., Brugada, J., Brugada, R., & Oliva, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084124 · Cited by 30
Extracellular volume is an independent predictor of arrhythmic burden in dilated cardiomyopathy
Rubiś, P., Dziewięcka, E. M., Banyś, P., Urbańczyk‐Zawadzka, M., Krupiński, M., Mielnik, M., Łach, J., Ząbek, A., Wiśniowska‐Śmiałek, S., Podolec, P. S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-03452-z · Cited by 30
Age, Sex, and Outcomes in Heart Failure With Reduced EF
Lam, C. S. P., Piña, I. L., Zheng, Y., Bonderman, D., Pouleur, A., Saldarriaga, C., Pieske, B. M., Blaustein, R. O., Nkulikiyinka, R., Westerhout, C. M., et al. (2023) · JACC Heart Failure · doi:10.1016/j.jchf.2023.06.020 · Cited by 30
Prevention of Sudden Cardiac Death in Adults With Congenital Heart Disease
Vehmeijer, J. T., Koyak, Z., Budts, W., Harris, L., Silversides, C. K., Oechslin, E. N., Bouma, B. J., Zwinderman, A. H., Mulder, B. J. M., & de Groot, J. R. (2017) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.116.005093 · Cited by 30
Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting
Röger, S., Rosenkaimer, S. L., Hohneck, A. L., Lang, S., El‐Battrawy, I., Rudic, B., Tülümen, E., Stach, K., Kuschyk, J., Akın, İ., et al. (2018) · BMC Cardiovascular Disorders · doi:10.1186/s12872-018-0790-8 · Cited by 30
Current diagnostic strategies for dilated cardiomyopathy: a comparison of imaging techniques
Porcari, A., Angelis, G. D., Romani, S., Paldino, A., Artico, J., Cannata, A. N., Gentile, P., Pinamonti, B., Merlo, M., & Sinagra, G. (2018) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2019.1550719 · Cited by 29
Waiting Period Before Implantable Cardioverter-Defibrillator Implantation in Newly Diagnosed Heart Failure With Reduced Ejection Fraction
DeFilippis, E. M., Butler, J., & Vaduganathan, M. (2017) · Circulation Heart Failure · doi:10.1161/circheartfailure.117.004478 · Cited by 30
Risk of Arrhythmic Death in Patients With Nonischemic Cardiomyopathy
Chrispin, J., Merchant, F. M., Lakdawala, N. K., Wu, K. C., Tomaselli, G. F., Navara, R., Torbey, E., Ambardekar, A. V., Kabra, R., Arbustini, E., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.05.064 · Cited by 29
Update on prevention and treatment of sudden cardiac arrest
Krokhaleva, Y., & Vaseghi, M. (2018) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.11.002 · Cited by 32
Outcomes of Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy Without Background Implantable Cardioverter Defibrillator Therapy
Santangeli, P., Tung, R. H., Xue, Y., Chung, F., Lin, Y., Biase, L. D., Zhan, X., Lin, C., Wei, W., Mohanty, S., et al. (2018) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2018.09.019 · Cited by 29
Updating the Risk Stratification for Sudden Cardiac Death in Cardiomyopathies: The Evolving Role of Cardiac Magnetic Resonance Imaging. An Approach for the Electrophysiologist
Kariki, O. K., Antoniou, C. K., Mavrogeni, S. I., & Gatzoulis, K. A. (2020) · Diagnostics · doi:10.3390/diagnostics10080541 · Cited by 29
Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy—Are there predictors of appropriate therapy?
Weissler‐Snir, A., Dorian, P., Rakowski, H., Care, M. E., & SPEARS, D. A. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.08.009 · Cited by 29
Contemporary Management of Heart Failure in Patients With Diabetes
Shaw, J. A., & Cooper, M. E. (2020) · Diabetes Care · doi:10.2337/dc20-2173 · Cited by 29
QRS micro-fragmentation as a mortality predictor
Hnatkova, K., Andršová, I., Novotný, T., Britton, A. R., Shipley, M. J., Vandenberk, B., Sprenkeler, D. J., Junttila, J. M., Reichlin, T., Schlögl, S., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac085 · Cited by 29
Head‐to‐head comparison between recommendations by the ESC and ACC / AHA / HFSA heart failure guidelines
Bayés‐Genís, A., Aimo, A., Metra, M., Anker, S. D., Seferovic, P. M., Rapezzi, C., Castiglione, V., Núñez, J. E., Emdin, M., Rosano, G. M. C., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2542 · Cited by 30
Arrhythmic Risk Stratification in Patients With Idiopathic Dilated Cardiomyopathy
Stolfo, D., Ceschia, N., Zecchin, M., Luca, A. D., Gobbo, M., Barbati, G., Gigli, M., Masè, M., Pinamonti, B., Pivetta, A., et al. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.02.055 · Cited by 29
Impairment of Quality of Life among Patients with Wearable Cardioverter Defibrillator Therapy (LifeVest®): A Preliminary Study
Lackermair, K., Schuhmann, C. G., Kubieniec, M., Riesinger, L. M., Klier, I., Stocker, T. J., Kääb, S., Estner, H., & Fichtner, S. (2018) · BioMed Research International · doi:10.1155/2018/6028494 · Cited by 29
A Novel Risk Stratification Score for Sudden Cardiac Death Prediction in Middle-Aged, Nonischemic Dilated Cardiomyopathy Patients: The ESTIMATED Score
Li, X., Fan, X., Li, S., Sun, W., Shivkumar, K., Zhao, S., Lu, M., & Yao, Y. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.11.009 · Cited by 28
Established and Emerging Mechanisms in the Pathogenesis of Arrhythmogenic Cardiomyopathy: A Multifaceted Disease
Gao, S., Puthenvedu, D., Lombardi, R., & Chen, S. N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176320 · Cited by 28
Dutch Outcome in Implantable Cardioverter‐Defibrillator Therapy: Implantable Cardioverter‐Defibrillator–Related Complications in a Contemporary Primary Prevention Cohort
van Barreveld, M., Verstraelen, T. E., van Dessel, P. F. H. M., Boersma, L. V. A., Delnoy, P. P. H. M., Tuinenburg, A. E., Theuns, D. A. M. J., van der Voort, P. H., Kimman, G. P., Buskens, E., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.018063 · Cited by 28
Left ventricular shape predicts arrhythmic risk in fibrotic dilated cardiomyopathy
Balaban, G., Halliday, B. P., Hammersley, D. J., Rinaldi, C. A., Prasad, S. K., Bishop, M. J., & Lamata, P. (2021) · EP Europace · doi:10.1093/europace/euab306 · Cited by 26
Temporal trends in initiation of mineralocorticoid receptor antagonists and risk of subsequent withdrawal in patients with heart failure: a nationwide study in Denmark from 2003–2017
Zahir, D., Bonde, A. N., Madelaire, C., Malmborg, M. W., Butt, J. H., Fosbøl, E. L., Gislason, G., Torp-Pedersen, C. T., Andersson, C., Rossignol, P., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2418 · Cited by 28
Self-citation
MAgnetic resonance imaging based DUal lead cardiac Resynchronization therapy: A prospectIve Left Bundle Branch Pacing study (MADURAI LBBP study)
Ponnusamy, S. S., Ganesan, V., Ramalingam, V., Syed, T., Mariappan, S., Murugan, S., Kumar, M., Anand, V., Murugan, M., & Vijayaraman, P. (2023) · Heart Rhythm · doi:10.1016/j.hrthm.2023.05.019 · Cited by 28
Imagenetics for Precision Medicine in Dilated Cardiomyopathy
Antonopoulos, A. S., Xintarakou, A., Protonotarios, A., Lazaros, G. A., Miliou, A., Tsioufis, K. P., & Vlachopoulos, C. V. (2024) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.123.004301 · Cited by 27
Heart failure 2016: still more questions than answers
Metra, M., Carubelli, V., Ravera, A., & Coats, A. J. S. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.10.060 · Cited by 27
Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy: A propensity score‐matched analysis of in‐hospital outcomes in the United States
Briceno, D. F., Gupta, T., Romero, J. E., Kolte, D. S., Khera, S., Villablanca, P. A., Tran, A., Mohanty, S., Trivedi, C. G., Mohanty, P. K., et al. (2018) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13452 · Cited by 27
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy
Barison, A., Aimo, A., Mirizzi, G., Castiglione, V., Ripoli, A., Panchetti, L., Rossi, A., Giannoni, A., Startari, U., Aquaro, G. D., et al. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.02.028 · Cited by 27
Time to Shock the System: Moving Beyond the Current Paradigm for Primary Prevention Implantable Cardioverter‐Defibrillator Use
Merchant, F. M., Levy, W. C., & Kramer, D. B. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015139 · Cited by 27
Prognostic value of cardiovascular magnetic resonance T1 mapping techniques in non-ischemic dilated cardiomyopathy: A systematic review and meta-analysis
Kiaos, A., Antonakaki, D., Bazmpani, M.-A., Karvounis, C., Rimoldi, O. E., & Karamitsos, T. D. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.04.052 · Cited by 27
Prevention of sudden death in heart failure with reduced ejection fraction: do we still need an implantable cardioverter‐defibrillator for primary prevention?
Abdelhamid, M., Rosano, G. M. C., Metra, M., Adamopoulos, S. N., Böhm, M., Chioncel, O. D., Filippatos, G. S., Jankowska, E. A., Lopatin, Y. M., Lund, L. H., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2594 · Cited by 29
Baseline clinical characteristics of heart failure patients with reduced ejection fraction enrolled in the BUDAPEST‐CRT Upgrade trial
Merkely, B. P., Gellér, L., Zima, E., Osztheimer, I., Molnár, L., Földesi, C., Duray, G. Z., Wranicz, J. K., Németh, M., Gościńska-Bis, K., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2609 · Cited by 27
GDF‐15 is a better complimentary marker for risk stratification of arrhythmic death in non‐ischaemic, dilated cardiomyopathy than soluble ST 2
Stojković, S., Kaider, A., Koller, L., Brekalo, M., Wojta, J., Diedrich, A., Demyanets, S., & Pezawas, T. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13540 · Cited by 27
Importance of beta-blocker dose in prevention of ventricular tachyarrhythmias, heart failure hospitalizations, and death in primary prevention implantable cardioverter-defibrillator recipients: a Danish nationwide cohort study
Ruwald, A., Gislason, G., Vinther, M., Johansen, J. B., Nielsen, J. C., Philbert, B. T., Torp-Pedersen, C. T., Riahi, S., & Jøns, C. (2018) · EP Europace · doi:10.1093/europace/euy077 · Cited by 27
Self-citation
JCS / JHRS 2024 Guideline Focused Update on Management of Cardiac Arrhythmias
Iwasaki, Y., Noda, T., Akao, M., Fujino, T., Hirano, T., Inoue, K., Kusano, K., Nagai, T., Satomi, K., Shinohara, T., et al. (2025) · Journal of Arrhythmia · doi:10.1002/joa3.70033 · Cited by 28
The evolving risk of sudden cardiac death after heart transplant. An analysis of the ISHLT Thoracic Transplant Registry
Alba, A. C., Fan, C. S., Manlhiot, C., Dipchand, A. I., Stehlik, J., & Ross, H. J. (2019) · Clinical Transplantation · doi:10.1111/ctr.13490 · Cited by 28
Lumpers and splitters: the bumpy road to precision medicine
Lüscher, T. F. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz644 · Cited by 27
Cardiac Electronic Devices: Future Directions and Challenges
Kotalczyk, A., Kalarus, Z. F., Wright, D. J., Boriani, G., & Lip, G. Y. H. (2020) · Medical Devices Evidence and Research · doi:10.2147/mder.s245625 · Cited by 29
Different left ventricular remodelling patterns and clinical outcomes between non-ischaemic and ischaemic aetiologies in heart failure patients receiving sacubitril/valsartan treatment
Lee, Y., Chiou, W., Hsu, C., Lin, P., Liang, H., Chung, F., Liao, C., Lin, W., & Chang, H. (2020) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvaa125 · Cited by 26
Temporal Incidence of Appropriate and Inappropriate Therapy and Mortality in Secondary Prevention ICD Patients by Cardiac Diagnosis
Ruwald, M. H., Ruwald, A., Johansen, J. B., Gislason, G., Lindhardt, T. B., Nielsen, J. C., Torp-Pedersen, C. T., Riahi, S., Vinther, M., & Philbert, B. T. (2021) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2020.11.005 · Cited by 26
Self-citation
A novel risk model for predicting potentially life-threatening arrhythmias in non-ischemic dilated cardiomyopathy (DCM-SVA risk)
Kayvanpour, E., Sammani, A., Sedaghat‐Hamedani, F., Lehmann, D. H., Broezel, A., Koelemen, J., Chmielewski, P., Curjol, A., Socié, P., Miersch, T., et al. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.07.002 · Cited by 26
Management of Heart Failure With Reduced Ejection Fraction
Rashid, A. M., Khan, M. S., Fudim, M., DeWald, T. A., DeVore, A. D., & Butler, J. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.101596 · Cited by 31
Heart Failure and Sudden Cardiac Death
Saour, B., Smith, B., & Yancy, C. W. (2017) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2017.07.010 · Cited by 27
Left Bundle Branch Block-associated Cardiomyopathy: A New Approach
Ponnusamy, S. S., Vijayaraman, P., & Ellenbogen, K. A. (2024) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2024.14 · Cited by 25
Association of Diabetes and Kidney Function According to Age and Systolic Function with the Incidence of Sudden Cardiac Death and Non-Sudden Cardiac Death in Myocardial Infarction Survivors with Heart Failure
Coiro, S., Girerd, N., Sharma, A., Rossignol, P., Tritto, I., Pitt, B., Pfeffer, M. A., McMurray, J. J. V., Ambrosio, G., Dickstein, K., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1541 · Cited by 25
Outcome of implantable cardioverter defibrillator in cardiac sarcoidosis: a systematic review and meta-analysis
Halawa, A., Jain, R., Turagam, M. K., Kusumoto, F. M., Woldu, H. G., & Gautam, S. (2020) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-020-00705-1 · Cited by 25
Extended Follow-Up After Wearable Cardioverter-Defibrillator Period: The PROLONG-II Study
Müller‐Leisse, J., Brunn, J., Zormpas, C., Hohmann, S., Hillmann, H. A. K., Eiringhaus, J., Bauersachs, J. K., Veltmann, C., & Duncker, D. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13586 · Cited by 25
Predictors of primary prevention implantable cardioverter‐defibrillator use in heart failure with reduced ejection fraction: impact of the predicted risk of sudden cardiac death and all‐cause mortality
Schrage, B., Lund, L. H., Benson, L., Dahlström, U., Shadman, R., Linde, C. M., Braunschweig, F., Levy, W. C., & Savarese, G. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2530 · Cited by 25
Chinese expert consensus on the diagnosis and treatment of chronic heart failure in elderly patients (2021)
Wang, X., Zhang, C., & Editing Group of the Chinese Expert Consensus on the Diagnosis and Treatment of Chronic Heart Failure in Elderly Patients (2022) · Aging Medicine · doi:10.1002/agm2.12215 · Cited by 25
Guía ESC 2021 sobre estimulación cardiaca y terapia de resincronización
Glikson, M., Nielsen, J. C., Kronborg, M. B., Michowitz, Y., Auricchio, A., Barbash, I. M., Barrabés, J. A., Boriani, G., Braunschweig, F., Brignole, M., et al. (2022) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.10.025 · Cited by 28
Self-citation
Diretriz Brasileira de Dispositivos Cardíacos Eletrônicos Implantáveis – 2023
Teixeira, R. A., Fagundes, A. A., Baggio, J. M., de Oliveira, J. C., Medeiros, P. D. T. J., Valdigem, B. P., Teno, L. A. C., Silva, R. T., de Melo, C. S., Elías, J., et al. (2023) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20220892 · Cited by 53
Sex-specific outcomes with addition of defibrillation to resynchronisation therapy in patients with heart failure
Barra, S., Providencia, R. A., Duehmke, R. M., Bovéda, S., Marijon, É., Reitan, C., Borgquist, R., Klug, D., Defaye, P., Sadoul, N., et al. (2017) · Heart · doi:10.1136/heartjnl-2016-310677 · Cited by 25
Differential multivariable risk prediction of appropriate shock versus competing mortality - A prospective cohort study to estimate benefits from ICD therapy
Bergau, L., Willems, R., Sprenkeler, D. J., Fischer, T. H., Flevari, P. G., Hasenfuss, G. P., Katsaras, D. N., Kirova, A., Lehnart, S. E., Lüthje, L., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.06.103 · Cited by 25
Electrical Ventricular Remodeling in Dilated Cardiomyopathy
Mages, C., Gampp, H., Syren, P., Rahm, A., André, F., Frey, N., Lugenbiel, P., & Thomas, D. (2021) · Cells · doi:10.3390/cells10102767 · Cited by 24
Machine learning techniques for arrhythmic risk stratification: a review of the literature
Chung, C. T., Bazoukis, G., Lee, S., Liu, Y., Liu, T., Letsas, Κ. P., Armoundas, A. A., & Tse, G. (2022) · International Journal of Arrhythmia · doi:10.1186/s42444-022-00062-2 · Cited by 26
Frailty Status Modifies the Efficacy of ICD Therapy for Primary Prevention Among Patients With HF.
Segar, M. W., Keshvani, N., Singh, S., Patel, L., Parsa, S., Betts, T., Reeves, G. R., Mentz, R., Forman, D., Razavi, M., et al. (2023) · JACC. Heart failure · doi:10.1016/j.jchf.2023.06.009 · Cited by 19
Arrhythmic risk stratification in heart failure: Time for the next step?
Gatzoulis, K. A., Sideris, A., KANOUPAKIS, E. M., Sideris, S. K., Nikolaou, N. I., Antoniou, C. K., & Kolettis, T. M. (2017) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12430 · Cited by 24
Mortality Effect of ICD in Primary Prevention of Nonischemic Cardiomyopathy: A Meta‐Analysis of Randomized Controlled Trials
Luni, F. K., Singh, H., Khan, A. R., MALIK, S. A., Khawaja, O. A., Riaz, H., Lee‐Smith, W., Kabour, A., Richards, M., & Aasbo, J. D. (2017) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13192 · Cited by 24
Gender‐adjusted and age‐adjusted economic inpatient burden of congestive heart failure: cost and disability‐adjusted life‐year analysis
Salem, K., & Elkhateeb, O. (2017) · ESC Heart Failure · doi:10.1002/ehf2.12156 · Cited by 23
Implantable Cardioverter Defibrillators in Patients With Continuous Flow Left Ventricular Assist Devices: Utilization Patterns, Related Procedures, and Complications
Alvarez, P. A., Sperry, B. W., Pérez, A. L., YARANOV, D. M., Randhawa, V. K., Luthman, J., Cantillon, D. J., & Starling, R. C. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011813 · Cited by 24
Prevalence and prognostic association of ventricular arrhythmia in non-ischaemic heart failure patients: results from the DANISH trial
Boas, R., Thune, J. J., Pehrson, S. M., Køber, L., Nielsen, J. C., Videbæk, L. M., Haarbo, J., Korup, E., Bruun, N. E., Brandes, A., et al. (2020) · EP Europace · doi:10.1093/europace/euaa341 · Cited by 24
Self-citation
CarDiac magnEtic Resonance for prophylactic Implantable cardioVerter defibrillAtor ThErapy in Non-Dilated Left Ventricular Cardiomyopathy: a sub-study from the DERIVATE registry
Leo, I., Dellegrottaglie, S., Scatteia, A., Torella, D., Abete, R., Aquaro, G. D., Baggiano, A., Barison, A., Bogaert, J. G., Calò, L., et al. (2025) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeaf043 · Cited by 23
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure
On, Y. K. (2017) · International Journal of Arrhythmia · doi:10.18501/arrhythmia.2017.008 · Cited by 23
Long-Term Outcome of Catheter Ablation for Treatment of Bundle Branch Re-Entrant Tachycardia
Pathak, R. K., Fahed, J., Santangeli, P., Hyman, M. C., Liang, J. J., Kubala, M., Hayashi, T., Muser, D., Pathak, M., Kochar, A., et al. (2018) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2017.11.021 · Cited by 23
Cardiac resynchronization therapy: How did consensus guidelines from Europe and the United States evolve in the last 15 years?
Boriani, G., Ziacchi, M., Nesti, M., Battista, A., Placentino, F., Malavasi, V. L., Diemberger, I., & Padeletti, L. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.01.039 · Cited by 24
Effect of ICD implantation on cardiovascular outcomes in patients with cardiac amyloidosis: A systematic review and meta‐anaylsis
Halawa, A., Woldu, H. G., Gifft, K., & Alpert, M. (2020) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14541 · Cited by 23
Sudden Cardiac Death Prediction in Non-ischemic Dilated Cardiomyopathy: a Multiparametric and Dynamic Approach
Hammersley, D. J., & Halliday, B. P. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01343-9 · Cited by 23
Guideline-Directed Medical Therapy and the Risk of Death in Primary Prevention Defibrillator Recipients
Dhande, M., Rangavajla, G., Canterbury, A., Hamandi, M., Boricha, H., Newhouse, D., Osterhaus, E. C., Thoma, F. W., Mulukutla, S. R., Aronis, K. N., et al. (2022) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2022.05.001 · Cited by 23
Substrate‐dependent risk stratification for implantable cardioverter defibrillator therapies using cardiac magnetic resonance imaging: The importance of T1 mapping in nonischemic patients
Claridge, S., Mennuni, S., Jackson, T., Behar, J. M., Porter, B., Sieniewicz, B., Bostock, J., O'Neill, M. D., MURGATROYD, F. D., Gill, J. S., et al. (2017) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13226 · Cited by 23
Current Device Therapies for Sudden Cardiac Death Prevention – the ICD, Subcutaneous ICD and Wearable ICD
Chieng, D., Paul, V., & Denman, R. A. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.09.011 · Cited by 23
The Wearable Cardioverter-Defibrillator: Experience in 153 Patients and a Long-Term Follow-Up
Rosenkaimer, S., El‐Battrawy, I., Dreher, T. C., Gerhards, S., Röger, S., Kuschyk, J., Borggrefe, M. M., & Akın, İ. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030893 · Cited by 23
Cause of Death in Patients With Acute Heart Failure
Loungani, R. S., Teerlink, J. R., Metra, M., Allen, L. A., Butler, J., Carson, P. E., Chen, C., Cotter, G., Davison, B. A., Eapen, Z. J., et al. (2020) · JACC Heart Failure · doi:10.1016/j.jchf.2020.09.010 · Cited by 23
Inherited cardiomyopathies
Miles, C. J., Fanton, Z., Tome, M., & Behr, E. R. (2019) · BMJ · doi:10.1136/bmj.l1570 · Cited by 23
Role of Arrhythmic Phenotype in Prognostic Stratification and Management of Dilated Cardiomyopathy
Setti, M., Merlo, M., Gigli, M., Munaretto, L., Paldino, A., Stolfo, D., Gava, C. P. L. D., Medo, K., Gregorio, C., Luca, A. D., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3168 · Cited by 22
Sudden cardiac arrest: Limitations in risk-stratification and treatment, and the potential for digital technologies and artificial intelligence to improve prediction and outcomes
Srivats, S. S., Zghyer, F., Shahrori, Z., Albert, C. M., Al‐Khatib, S. M., Chugh, S. S., Etheridge, S. P., Goldberger, Z. D., Gopinathannair, R., Lakkireddy, D., et al. (2025) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2025.06.005 · Cited by 26
A Review of Driving Restrictions in Patients at Risk of Syncope and Cardiac Arrhythmias Associated with Sudden Incapacity: Differing Global Approaches to Regulation and Risk
Margulescu, A. D., & Anderson, M. H. (2019) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2019.13.2 · Cited by 22
Cardiac resynchronization therapy with or without defibrillator in patients with heart failure
Schrage, B., Lund, L. H., Melin, M., Benson, L., Uijl, A., Dahlström, U., Braunschweig, F., Linde, C. M., & Savarese, G. (2021) · EP Europace · doi:10.1093/europace/euab233 · Cited by 22
Electrophysiology practice in low- and middle-income countries: An updated review on access to care and health delivery
Khurshid, R., Awais, M. A., & Malik, J. (2023) · Heart Rhythm O2 · doi:10.1016/j.hroo.2022.09.002 · Cited by 22
Mind the Gap: Current Challenges and Future State of Heart Failure Care
McDonald, M. A., Ashley, E. A., Fedak, P. W. M., Hawkins, N. M., Januzzi, J. L., McMurray, J. J. V., Parikh, V. N., Rao, V., Svystonyuk, D. A., Teerlink, J. R., et al. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.08.023 · Cited by 22
Arrhythmic risk stratification in patients with dilated cardiomyopathy and intermediate left ventricular dysfunction
Merlo, M., Gentile, P., Artico, J., Cannata, A. N., Paldino, A., Angelis, G. D., Barbati, G., Alonge, M., Gigli, M., Pinamonti, B., et al. (2019) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000792 · Cited by 22
Sudden Cardiac Death as First Manifestation of Cardiovascular Disease
Skjelbred, T., Warming, P. E., Krøll, J., Andersen, M. P., Torp-Pedersen, C., Winkel, B. G., Tfelt‐Hansen, J., & Lynge, T. H. (2025) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2024.12.012 · Cited by 21
Self-citation
Cardiac resynchronization therapy pacemaker or cardiac resynchronization therapy defibrillator: what determines the choice?—findings from the ESC CRT Survey II
Normand, C., Linde, C. M., Bogale, N., Blomström‐Lundqvist, C., Auricchio, A., Stellbrink, C., Witte, K. K., Müllens, W., Sticherling, C., Marinskis, G., et al. (2019) · EP Europace · doi:10.1093/europace/euz002 · Cited by 21
The right time for palliative care in heart failure: a review of critical moments for palliative care intervention
Slavin, S. D., & Warraich, H. J. (2019) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2019.07.013 · Cited by 21
The Addition of a Defibrillator to Resynchronization Therapy Decreases Mortality in Patients With Nonischemic Cardiomyopathy
Doran, B., Mei, C., Varosy, P. D., Kao, D. P., Saxon, L. A., Feldman, A. M., DeMets, D. L., & Bristow, M. R. (2021) · JACC Heart Failure · doi:10.1016/j.jchf.2021.02.013 · Cited by 21
Periodic Repolarization Dynamics Identifies ICD Responders in Nonischemic Cardiomyopathy: A DANISH Substudy
Boas, R., Sappler, N., von Stuelpnagel, L., Klemm, M., Dixen, U., Thune, J., Pehrson, S., Køber, L., Nielsen, J., Videbæk, L., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.056464 · Cited by 16
Self-citation
The Role of AI in Characterizing the DCM Phenotype
Asher, C., Anton, E. P., Rizvi, M., Ruijsink, B., Chiribiri, A., Razavi, R., & Carr‐White, G. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.787614 · Cited by 21
Hypertrophic, Dilated, and Arrhythmogenic Cardiomyopathy: Where Are We?
Hadi, H. E., Freund, A., Desch, S., Thiele, H., & Majunke, N. (2023) · Biomedicines · doi:10.3390/biomedicines11020524 · Cited by 22
Rationale and design of a prospective study to assess the effect of left cardiac sympathetic denervation in chronic heart failure
Chin, A., Ntsekhe, M., Viljoen, C. A., Rossouw, J., Pennel, T. C., & Schwartz, P. J. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.08.012 · Cited by 21
Role of the Wearable Defibrillator in Newly Diagnosed Heart Failure
Duncker, D., & Veltmann, C. (2018) · Current Heart Failure Reports · doi:10.1007/s11897-018-0415-7 · Cited by 21
Cardiac resynchronization therapy using pacemakers vs defibrillators in patients with nonischemic cardiomyopathy: The United States experience from 2007 to 2014
Saba, S., McLaughlin, T. J., He, M., Althouse, A. D., Mulukutla, S. R., & Hernandez, I. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.04.028 · Cited by 21
Declining clinical benefit of ICD in heart failure patients: Temporal trend of mortality outcomes from randomized controlled trials
Disertori, M., Masè, M., Rigoni, M., Nollo, G., & Ravelli, F. (2019) · Journal of Cardiology · doi:10.1016/j.jjcc.2019.06.001 · Cited by 21
Application of Neural Networks to 12-Lead Electrocardiography ― Current Status and Future Directions ―
Goto, S., & Goto, S. (2019) · Circulation Reports · doi:10.1253/circrep.cr-19-0096 · Cited by 22
El momento óptimo para comenzar los cuidados paliativos en insuficiencia cardiaca: una revisión narrativa
Slavin, S. D., & Warraich, H. J. (2019) · Revista Española de Cardiología · doi:10.1016/j.recesp.2019.07.028 · Cited by 21
The effects of gender on electrical therapies for the heart: physiology, epidemiology, and access to therapies
Boriani, G., Lorenzetti, S., Cerbai, E., Oreto, G., Bronzetti, G., Malavasi, V. L., Biffi, A., Padeletti, L., Botto, G., & Diemberger, I. (2017) · EP Europace · doi:10.1093/europace/eux068 · Cited by 21
The administration of high-mobility group box 1 fragment prevents deterioration of cardiac performance by enhancement of bone marrow mesenchymal stem cell homing in the delta-sarcoglycan-deficient hamster
Kido, T., Miyagawa, S., Goto, T., Tamai, K., Ueno, T., Toda, K., Kuratani, T., & Sawa, Y. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202838 · Cited by 20
Left ventricular myocardial deformation pattern, mechanical dispersion, and their relation with electrocardiogram markers in the large population-based STANISLAS cohort: insights into electromechanical coupling
Verdugo‐Marchese, M., Coiro, S., Selton‐Suty, C., Kobayashi, M., Bozec, E., Lamiral, Z., Venner, C., Zannad, F. M., Rossignol, P., Girerd, N., et al. (2020) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeaa148 · Cited by 20

Authors: Køber, L., Thune, J. J., Nielsen, J. C., Haarbo, J., Videbæk, L., Korup, E., Jensen, G., Hildebrandt, P., Steffensen, F. H., Bruun, N. E., Eiskjær, H., Brandes, A., Thøgersen, A. M., Gustafsson, F., Egstrup, K., Videbæk, R., Hassager, C., Svendsen, J. H., Høfsten, D. E., Torp-Pedersen, C., & Pehrson, S.
Affiliations: University of Copenhagen (DK)
ORCID: Køber, Lars
Thune, Jens J.
Nielsen, Jens C.
Videbæk, Lars
Steffensen, Flemming H.
Bruun, Niels E.
Eiskjær, Hans
Brandes, Axel
Thøgersen, Anna M.
Gustafsson, Finn
Egstrup, Kenneth
Hassager, Christian
Svendsen, Jesper H.
Høfsten, Dan E.
Torp-Pedersen, Christian
Pehrson, Steen
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2016-09-29
Volume: 375
Issue: 13
Pages: 1221-1230
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1608029
OpenAlex: W2518530324
Cited by: 1,763
References: 18
Citations by year: 2026: 104 · 2025: 138 · 2024: 139 · 2023: 170 · 2022: 182 · 2021: 177 · 2020: 196 · 2019: 212 · 2018: 200 · 2017: 213 · 2016: 28
FWCI: 179.55
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion, other-oa)
Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Scopus (Elsevier) (submittedVersion)
VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
Funders: Bristol-Myers Squibb
Pfizer
AstraZeneca
Sanofi
Gilead Sciences
Hjerteforeningen
Boston Scientific Corporation
TrygFonden
Servier
St. Jude Medical
Biosense Webster
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Health Sciences › Medicine › Emergency Medicine › Cardiac Arrest and Resuscitation
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Keywords: implantable cardioverter-defibrillator, prophylactic ICD, heart failure with reduced ejection fraction, non-ischemic heart failure, sudden cardiac death, all-cause mortality, cardiac resynchronization therapy, device-related infection, left ventricular ejection fraction, DANISH trial
MeSH terms: Aged, Cardiac Pacing, Artificial, Cardiovascular Diseases, Electrocardiography, Female, Follow-Up Studies, Humans, Male, Middle Aged, Mortality, Stroke Volume, Death, Sudden, Cardiac, Defibrillators, Implantable, Heart Failure, Systolic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks